Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Nabriva Therapeutics (NBRV) - P/B ratio
P/B ratio as of May 2024 : -1.04
According to Nabriva Therapeutics
's latest financial reports the company has a price-to-book ratio of -1.04.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nabriva Therapeutics - P/B ratio (from 2017 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.2260 | -64.51% |
| 2021-12-31 | 0.6367 | -58.64% |
| 2020-12-31 | 1.54 | -49.09% |
| 2019-12-31 | 3.02 | 112.08% |
| 2018-12-31 | 1.43 | -46.67% |
| 2017-12-31 | 2.67 | |
| 2016-12-31 | N/A | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -374.52% | 🇺🇸 USA |